1. "2022"
Formats
  1. Journal Article (2449)
  2. Meeting Abstract (2196)
  3. Review (615)
  4. Editorial (363)
  5. Book Section (139)
  6. Correspondence (117)
  7. Guidelines (112)
  8. Research Letter (82)
  9. Miscellaneous (60)
  10. Conference Paper (29)
  11. Book Whole (6)
Groups
  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Alexander Drilon (85)
  3. Saad Usmani (83)
  4. Sergio Giralt (77)
  5. Marc Ladanyi (72)
  6. Gilles Salles (69)

More People

Years
  1. 2022 (6168)
Publications
  1. Journal of Clinical Oncology (520)
  2. Blood (319)
  3. Cancer Research (191)
  4. Annals of Oncology (158)
  5. Annals of Surgical Oncology (134)
  6. International Journal of Radiation Oncology, Biology, Physics (132)

More Publications

Publishers
  1. Elsevier Inc. (794)
  2. American Society of Clinical Oncology (583)
  3. Springer (440)
  4. Nature Publishing Group (379)
  5. American Society of Hematology (369)
  6. Oxford University Press (360)

More Publishers

Results (6168)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I dose escalation study of a tegavivint (BC2059) a first-in-class TBL1 inhibitor for patients with progressive, unresectable desmoid tumors
    Meeting Abstract

    Cranmer, L.; Razak, A. A.; Ratan, R.; Choy, E.; George, S.; Liebner, D.; Stenehjem, D.; Gounder, M.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Fanconi anemia pathway deficiency drives copy number variation in squamous cell carcinoma
    Meeting Abstract

    Webster, A. L.; Sanders, M. A.; Patel, K.; Dietrich, R.; Noonan, R. J.; Lach, F. P.; White, R. R.; Goldfarb, A. M.; Hadi, K.; Edwards, M. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Circulating tumor DNA is associated with response and survival in patients with advanced leiomyosarcoma
    Meeting Abstract

    Madanat-Harjuoja, L.; Klega, K.; Lu, Y.; Shulman, D. S.; Thorner, A. R.; Nag, A.; Tap, W.; Reinke, D. K.; Diller, L.; Ballman, K. V.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • First-in-human trial of intravenous MEDI9253, an oncolytic virus, in combination with durvalumab in patients with advanced solid tumors
    Meeting Abstract

    Purroy, N.; Durham, N.; Phillips, M.; Hattersley, M. M.; Jung, L.; Davar, D.; Zamarin, D.; Johanns, T. M.; Puzanov, I.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase 1/2 trial to evaluate the safety and antitumor activity of tipifarnib and alpelisib for patients with HRAS-overexpressing and/or PIK3CA-mutated/amplified recurrent/metastatic head and neck squamous cell carcinoma (The KURRENT trial)
    Meeting Abstract

    Hanna, G. J.; Batista, C. P.; Ho, A. L.; Gillison, M. L.; Adkins, D.; Dayoub, A.; Martell, B.; Leoni, M.; Dale, S.; Nie, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • (R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive tumorigenesis in IDH-mutant cancers
    Meeting Abstract

    Gunn, K. E.; Myllykoski, M.; Cao, J.; Huang, B.; Rouaisnel, B.; Diplas, B.; Levitt, M. M.; Looper, R.; Doench, J. G.; Ligon, K. L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A genetic-metabolic axis of metastatic liver organotropism
    Meeting Abstract

    Rogava, M.; Melms, J. C.; Davis, S.; Hug, C.; Ngo, B.; Lee, M. J.; Ho, P.; Amin, A. D.; Wang, Y.; Chen, S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Biomarker assessment of PTEN protein expression and gene expression profiling (GEP) in a phase III study of copanlisib in combination with rituximab in patients with indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Chaturvedi, S.; Schulz, A.; Soler, L. M.; Childs, B. H.; Matasar, M.; Zinzani, P. L.
    Cancer Research (2022)

    Fulltext@MSK | Save